DK1173153T3 - Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler - Google Patents

Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler

Info

Publication number: DK1173153T3
Authority: DK; Denmark
Prior art keywords: long chain; active ingredient; contain; drug; compositions
Prior art date: 1999-04-01

Application number

DK00919874T

Other languages

English (en)

Inventor

Nijs Henrik De

Elizabeth A Perry

Susan Chandler

Josephine Joan Chr Ferdinando

Original Assignee

Scherer Corp R P

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-01

Filing date

2000-03-29

Publication date

2006-02-20

2000-03-29 Application filed by Scherer Corp R P filed Critical Scherer Corp R P

2006-02-20 Application granted granted Critical

2006-02-20 Publication of DK1173153T3 publication Critical patent/DK1173153T3/da

Links

239000004094 surface-active agent Substances 0.000 title abstract 2
239000008183 oral pharmaceutical preparation Substances 0.000 title 1
150000003626 triacylglycerols Chemical class 0.000 title 1
239000007788 liquid Substances 0.000 abstract 5
239000004480 active ingredient Substances 0.000 abstract 3
229940079593 drug Drugs 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 1
235000021588 free fatty acids Nutrition 0.000 abstract 1
125000005456 glyceride group Chemical group 0.000 abstract 1
239000007887 hard shell capsule Substances 0.000 abstract 1
150000004668 long chain fatty acids Chemical class 0.000 abstract 1
229960000746 testosterone undecanoate Drugs 0.000 abstract 1
UDSFVOAUHKGBEK-CNQKSJKFSA-N testosterone undecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 UDSFVOAUHKGBEK-CNQKSJKFSA-N 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00919874T 1999-04-01 2000-03-29 Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler DK1173153T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9907715.8A GB9907715D0 (en)	1999-04-01	1999-04-01	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
DK1173153T3 true DK1173153T3 (da)	2006-02-20

Family

ID=10850947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00919874T DK1173153T3 (da)	1999-04-01	2000-03-29	Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler

Country Status (23)

Country	Link
EP (1)	EP1173153B1 (da)
JP (1)	JP4636692B2 (da)
AT (1)	ATE311177T1 (da)
AU (1)	AU763971B2 (da)
BR (1)	BRPI0009373B8 (da)
CA (1)	CA2366754C (da)
CZ (1)	CZ301724B6 (da)
DE (1)	DE60024429T2 (da)
DK (1)	DK1173153T3 (da)
ES (1)	ES2251991T3 (da)
GB (1)	GB9907715D0 (da)
HK (1)	HK1040364B (da)
HU (1)	HU227155B1 (da)
IL (2)	IL145567A0 (da)
MX (1)	MXPA01009817A (da)
NO (1)	NO331396B1 (da)
NZ (1)	NZ514649A (da)
PL (1)	PL196823B1 (da)
RU (1)	RU2207859C1 (da)
SI (1)	SI1173153T1 (da)
TR (1)	TR200102861T2 (da)
WO (1)	WO2000059482A1 (da)
ZA (1)	ZA200108457B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20150374826A1 (en) *	1999-06-30	2015-12-31	Lipocine Inc.	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AUPR573001A0 (en) *	2001-06-15	2001-07-12	Glaxo Wellcome Australia Ltd	Lymphatic drug delivery system
US7125568B2 (en)	2001-08-23	2006-10-24	Sung Michael T	Lipophilic drug compositions
KR100533458B1 (ko)	2002-07-20	2005-12-07	대화제약 주식회사	파클리탁셀의 가용화용 조성물 및 그의 제조 방법
KR100533460B1 (ko) *	2002-07-20	2005-12-08	대화제약 주식회사	난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101152470B1 (ko)	2003-08-13	2012-06-01	바이오콘 리미티드	치료제용 마이크로-입자 지방산 염 고형 투약 제형
US8241664B2 (en) *	2005-04-15	2012-08-14	Clarus Therapeutics, Inc	Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en)	2010-04-12	2013-07-23	Clarus Therapeutics Inc	Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
CN1853728A (zh) *	2005-04-19	2006-11-01	上海天博生物科技有限公司	一种改善药物或营养物口服吸收的方法、配方及其应用
JP4889262B2 (ja)	2005-08-19	2012-03-07	理研ビタミン株式会社	脂溶性薬剤組成物
GB0807605D0 (en) *	2008-04-28	2008-06-04	Diurnal Ltd	Lipid composition
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
US9375437B2 (en)	2010-06-18	2016-06-28	Lipocine Inc.	Progesterone containing oral dosage forms and kits
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
US8951996B2 (en) *	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
CN104427977B (zh)	2012-05-10	2018-02-02	佩因拉佛姆有限公司	局部麻醉剂的储库制剂及其制备方法
EP2866789B1 (en)	2012-06-28	2018-08-01	Johnson & Johnson Consumer Inc.	Racecadotril lipid compositions
US9801819B2 (en)	2012-06-28	2017-10-31	Johnson & Johnson Consumer Inc.	Racecadotril compositions
EP2934591B1 (en)	2012-12-20	2017-08-09	Solural Pharma Aps	Solid oral dosage form of testosterone derivative
US10245273B2 (en)	2013-12-26	2019-04-02	Clarus Therapeutics, Inc.	Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
WO2015193224A1 (en) *	2014-06-17	2015-12-23	Merck Sharp & Dohme B.V.	Stable formulations of testosterone undecanoate
KR102397569B1 (ko)	2014-06-19	2022-05-12	솔루랄 파마 에이피에스	친유성 화합물의 고형 경구 투여 형태
WO2016033549A2 (en)	2014-08-28	2016-03-03	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
JP2018522854A (ja)	2015-06-22	2018-08-16	リポカインインコーポレーテッド	１７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
CA3078723A1 (en)	2016-11-28	2018-05-31	Nachiappan Chidambaram	Oral testosterone undecanoate therapy
UA128186C2 (uk)	2017-11-27	2024-05-01	Умекрайн Когнішн Аб	ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 3<font face="Symbol">a</font>-ЕТИНІЛ-3<font face="Symbol">b</font>-ГІДРОКСІАНДРОСТАН-17-ОНУ ОКСИМУ
EP3824296B1 (en)	2018-07-20	2026-04-01	Lipocine Inc.	Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases
US11564933B2 (en)	2019-04-12	2023-01-31	Tolmar, Inc.	Methods of treating testosterone deficiency
CN116456981A (zh) *	2020-11-19	2023-07-18	辉瑞爱尔兰制药公司	用于改善的grp抑制剂递送的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5218811A (en) *	1975-08-01	1977-02-12	Eisai Co Ltd	Preparation of aqueous solution of fat- soluble substances
JPS61221131A (ja) *	1985-03-28	1986-10-01	Eisai Co Ltd	吸収促進したユビデカレノン含有組成物
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
GB9415810D0 (en) *	1994-08-04	1994-09-28	Jerrow Mohammad A Z	Composition
GB9608719D0 (en) *	1996-04-26	1996-07-03	Scherer Ltd R P	Pharmaceutical compositions
JP2002541111A (ja) *	1999-04-01	2002-12-03	アクゾ・ノベル・エヌ・ベー	ウンデカン酸テストステロンとヒマシ油を含む調合物

1999
- 1999-04-01 GB GBGB9907715.8A patent/GB9907715D0/en not_active Ceased
2000
- 2000-03-29 PL PL350094A patent/PL196823B1/pl unknown
- 2000-03-29 MX MXPA01009817A patent/MXPA01009817A/es active IP Right Grant
- 2000-03-29 EP EP00919874A patent/EP1173153B1/en not_active Expired - Lifetime
- 2000-03-29 SI SI200030794T patent/SI1173153T1/sl unknown
- 2000-03-29 CZ CZ20013460A patent/CZ301724B6/cs not_active IP Right Cessation
- 2000-03-29 NZ NZ514649A patent/NZ514649A/en not_active IP Right Cessation
- 2000-03-29 WO PCT/US2000/008426 patent/WO2000059482A1/en not_active Ceased
- 2000-03-29 ES ES00919874T patent/ES2251991T3/es not_active Expired - Lifetime
- 2000-03-29 JP JP2000609046A patent/JP4636692B2/ja not_active Expired - Lifetime
- 2000-03-29 HU HU0201444A patent/HU227155B1/hu unknown
- 2000-03-29 AU AU40494/00A patent/AU763971B2/en not_active Expired
- 2000-03-29 RU RU2001129365/14A patent/RU2207859C1/ru active
- 2000-03-29 DE DE60024429T patent/DE60024429T2/de not_active Expired - Lifetime
- 2000-03-29 BR BRPI0009373A patent/BRPI0009373B8/pt not_active IP Right Cessation
- 2000-03-29 AT AT00919874T patent/ATE311177T1/de active
- 2000-03-29 IL IL14556700A patent/IL145567A0/xx active IP Right Grant
- 2000-03-29 DK DK00919874T patent/DK1173153T3/da active
- 2000-03-29 TR TR2001/02861T patent/TR200102861T2/xx unknown
- 2000-03-29 HK HK02100518.1A patent/HK1040364B/en not_active IP Right Cessation
- 2000-03-29 CA CA002366754A patent/CA2366754C/en not_active Expired - Lifetime
2001
- 2001-09-23 IL IL145567A patent/IL145567A/en not_active IP Right Cessation
- 2001-09-28 NO NO20014719A patent/NO331396B1/no not_active IP Right Cessation
- 2001-10-15 ZA ZA200108457A patent/ZA200108457B/en unknown

Also Published As

Publication number	Publication date
HUP0201444A2 (hu)	2002-11-28
NO20014719D0 (no)	2001-09-28
IL145567A0 (en)	2002-06-30
CZ20013460A3 (cs)	2002-06-12
JP4636692B2 (ja)	2011-02-23
TR200102861T2 (tr)	2004-12-21
BRPI0009373B8 (pt)	2021-05-25
DE60024429D1 (de)	2006-01-05
BR0009373A (pt)	2002-01-29
AU4049400A (en)	2000-10-23
EP1173153B1 (en)	2005-11-30
MXPA01009817A (es)	2002-07-30
DE60024429T2 (de)	2006-08-03
ES2251991T3 (es)	2006-05-16
RU2207859C1 (ru)	2003-07-10
IL145567A (en)	2006-04-10
EP1173153A1 (en)	2002-01-23
NZ514649A (en)	2003-09-26
BRPI0009373B1 (pt)	2015-09-01
WO2000059482A1 (en)	2000-10-12
PL350094A1 (en)	2002-11-04
SI1173153T1 (sl)	2006-06-30
CA2366754A1 (en)	2000-10-12
NO331396B1 (no)	2011-12-12
NO20014719L (no)	2001-10-24
CA2366754C (en)	2009-07-14
AU763971B2 (en)	2003-08-07
ZA200108457B (en)	2004-02-12
HUP0201444A3 (en)	2004-05-28
HK1040364A1 (en)	2002-06-07
CZ301724B6 (cs)	2010-06-02
PL196823B1 (pl)	2008-02-29
RU2001129365A (ru)	2004-02-20
EP1173153A4 (en)	2002-01-30
HK1040364B (en)	2006-02-10
JP2003526620A (ja)	2003-09-09
ATE311177T1 (de)	2005-12-15
GB9907715D0 (en)	1999-05-26
HU227155B1 (en)	2010-09-28

Publication	Publication Date	Title
NO20014719L (no)	2001-10-24	Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
KR100666016B1 (ko)	2007-01-10	테스토스테론 운데카노에이트 및 피마자유를 포함하는 제제
DK0904064T3 (da)	2001-12-17	Orale farmaceutiske præparater indeholdende kønshormoner
CA2294031A1 (en)	1999-02-11	Self-emulsifying formulation for lipophilic compounds
ATE215370T1 (de)	2002-04-15	Selbstemulgierende formulierung enthaltend lipophile verbindungen
ES2174814T3 (es)	2002-11-16	Acidos grasos esenciales destinados en la prevencion de accidentes cardio-vasculares.
PL318560A1 (en)	1997-06-23	Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
JP2002541111A5 (da)	2007-04-05
UY26303A1 (es)	2001-03-16	Composiciones farmacéuticas para administración oral y tópica
KR950031039A (ko)	1995-12-18	경구 투여 약제용 제제
AR016629A1 (es)	2001-07-25	Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
MY130474A (en)	2007-06-29	Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
ES2141049A1 (es)	2000-03-01	Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
JP2000159660A (ja)	2000-06-13	シクロスポリンカプセル剤
AR023235A1 (es)	2002-09-04	Formulaciones de androgenos
TH60756A (th)	2004-02-13	สูตรตำรับแอนโดรเจน
TH33003B (th)	2012-06-29	สูตรตำรับแอนโดรเจน